Industry News
Biota to boost Melbourne facilities
Biota (ASX:BTA) will expand its facilities in Melbourne to allow it to fulfil a $220m contract for the advanced development of a influenza antiviral in the US. [ + ]
Patrys publishes PAT-SM6 trial results
Melbourne's Patrys Limited (ASX:PAB) has published the results of a safety and tolerability trial of anti-cancer antibody PAT-SM6. [ + ]
Launch of the CEO survey at April member-only briefings
AusBiotech’s 2012 CEO Biotechnology Industry Position Survey will be launched by AusBiotech’s CEO, Dr Anna Lavelle, at the member-only briefings in April. [ + ]
Pharmaxis to get PBS tick for Bronchitol
Pharmaxis’ cystic fibrosis treatment Bronchitol is slated to be listed on the Pharmaceutical Benefits Scheme for reimbursement. [ + ]
Vale Andrew Baker
Biotechnology and pharmaceutical industry veteran and GBS Ventures partner, Dr Andrew Baker, died on Sunday March 18 from cancer. [ + ]
REVA Medical gets major new investors
A group of buyers including Elliott Management have purchased $23m worth of CDIs and shares in ASX-listed US medical device company REVA Medical (ASX:RVA). [ + ]
QRxPharma signs licensing deal with Actavis
QRxPharma (ASX:QRX) has closed a deal to license its dual-opioid pain product, MoxDuo IR, to pharmaceutical company Actavis. [ + ]
UTAS innovator wins international science award
Professor Emily Hilder, from the University of Tasmania, has won the prestigious LCGC 2012 Emerging Leader in Chromatography Award. This is the first time the award has been presented to an Australian researcher and the first time to a female researcher. [ + ]
Bioniche secures $19m finance facility
Dual-listed biotech Bioniche (ASX:BNC) has negotiated to receive a $19m, non-dilutive finance facility from the USA's Capital Royalty. [ + ]
Brisbane opens new centre for neuromodulation
The $10 million Asia-Pacific Centre for Neuromodulation will focus on deep brain stimulation and seek to become an international hub for brain research. [ + ]
What’s New in LAB Technology survey winner
Congratulations to Carla Mathews from Austin Health, who has won an iPad after completing the recent What’s New in LAB Technology survey. [ + ]
LBT Innovations applies for APAS patents
LBT Innovations (ASX:LBT) has filed applications for international patents for its second invention, the Automated Plate Assessment System (APAS). [ + ]
Pharmaxis close to EU approval for Bronchitol
Pharmaxis (ASX:PXS) has been notified that it should soon receive approval for its marketing application to sell its Bronchitol cystic fibrosis treatment in the EU. [ + ]
STAT3 gene highlights delicate immune balance
Researchers have found the STAT3 gene is central to proper immune function, raising hope of new medications to treat immunodeficient and autoimmune disorders. [ + ]
IQnovate signs MOU with agricultural biotech group
Contract medical company IQnovate has signed a memorandum of understanding with JH Biotech Australasia to commercialise and extract research and development efficiencies related to a range of biotechnology products, including ones suitable for animal nutrition. [ + ]
